Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interacting of VEGFR-2

Cellular Signalling

Volumn 24, Issue 1, 2012, Pages 131-139

  Rho, Seung Bae ^a   Song, Yong Jung ^a   Lim, Myong Cheol ^a   Lee, Seung Hoon ^b   Kim, Boh Ram ^a   Park, Sang Yoon ^a  

^a National Cancer Center   (South Korea)

^b Yongin University   (South Korea)

Author keywords

Angiogenesis; Apoptosis; Endothelial cell; PI3K mTOR p70S6K pathway; Programmed cell death 6

Indexed keywords

CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA; MAMMALIAN TARGET OF RAPAMYCIN; MEMBRANE RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROGRAMMED DEATH 6 RECEPTOR; PROTEIN KINASE B; S6 KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

ANGIOGENESIS INHIBITORS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CALCIUM-BINDING PROTEINS; CELL LINE; CELL MOVEMENT; CELL PROLIFERATION; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; GLYCOGEN SYNTHASE KINASE 3; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LUCIFERASES; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-AKT; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; TOR SERINE-THREONINE KINASES; TWO-HYBRID SYSTEM TECHNIQUES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

MAMMALIA;

EID: 80755175776     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2011.08.013     Document Type: Article

References (33)

1. Vito P., Lacana E., D'Adamio L. Science 1996, 271:521-525.
2. Krebs J., Saremaslani P., Caduff R. Biochimica et Biophysica Acta 2002, 1600:68-73.
3. Missotten M., Nochols A., Rieger K., Sadoul Alix R. Cell Death and Differentiation 1999, 6:124-129.
4. Suzuki H., Kawasaki M., Inuzuka T., Okumura M., Kakiuchi T., Shibata H., Wakatsuki S., Maki M. Structure 2008, 16:1562-1573.
5. Jung Y.S., Kim K.S., Kim K.D., Lim J.S., Kim J.W., Kim E. Biochemical and Biophysical Research Communications 2001, 288:420-426.
6. Satoh H., Shibata H., Nakano Y., Kitaura Y., Maki M. Biochemical and Biophysical Research Communications 2002, 291:1166-1172.
7. Lee J.H., Rho S.B., Chun T. Biotechnology Letters 2005, 27:1011-1015.
8. Katoh K., Suzuki H., Terasawa Y., Mizuno T., Yasuda J., Shibata H., Maki M. Biochemical Journal 2005, 391:677-685.
9. Yamasaki A., Tani K., Yamamoto A., Kitamura N., Komada M. Molecular Biology of the Cell 2006, 17:4876-4887.
10. Shibata H., Suzuki H., Kakiuchi T., Inuzuka T., Yoshida H., Mizuno T., Maki M.M. Journal of Biological Chemistry 2008, 283:9623-9632.
11. la Cour J.M., Mollerup J., Winding P., Tarabykina S., Sehested M., Berchtold M.W. American Journal of Pathology 2003, 163:81-89.
12. Yamada Y., Arao T., Gotoda T., Taniguchi H., Oda I., Shirao K., Shimada Y., Hamaguchi T., Kato K., Hamano T., Koizumi F., Tamura T., Saito D., Shimoda T., Saka M., Fukagawa T., Katai H., Sano T., Sasako M., Nishio K. Cancer Science 2008, 99:2193-2199.
13. Lee O.H., Kim Y.M., Lee Y.M., Moon E.J., Lee D.J., Kim J.H., Kim K.W., Kwon Y.G. Biochemical and Biophysical Research Communications 1999, 264:743-750.
14. Rho S.B., Lee K.H., Kim J.W., Shiba K., Jo Y.J., Kim S. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:10128-10133.
15. Plate K.H., Breier G., Weich H.A., Risau W. Nature 1992, 359:845-848.
16. Breier G. Advances in Experimental Medicine and Biology 2000, 476:57-66.
17. Ferrara N. American Journal of Physiology. Cell Physiology 2000, 280:C1358-C1366.
18. Meyer R.D., Rahimi N. Annals of the New York Academy of Sciences 2003, 995:200-207.
19. Green D.R., Evan G.I. Cancer Cell 2002, 1:19-30.
20. Soengas M.S., Capodieci P., Polsky D., Mora J., Esteller M., Opitz-Araya X., McCombie R., Herman J.G., Gerald W.L., Lazebnik Y.A., Cordon-Cardo S.W. Nature 2001, 409:207-211.
21. Subramanian L., Crabb J.W., Cox J., Durussel I., Walker T.M., van Ginkel P.R., Bhattacharya S., Dellaria J.M., Palczewski K., Polans A.S. Biochemistry 2004, 43:11175-11186.
22. la Cour J.M., Høj B.R., Mollerup J., Simon R., Sauter G., Berchtold M.W. Molecular Oncology 2008, 1:431-439.
23. Folkman J., Shing Y. Journal of Biological Chemistry 1992, 267:10931-10934.
24. Risau W. Nature 1997, 386:671-674.
25. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Nature 2000, 407:242-248.
26. Meyer R.D., Singh A., Majnoun F., Latz C., Lashkari K., Rahimi N. Oncogene 2004, 23:5523-5531.
27. Xia C., Meng Q., Cao Z., Shi X., Jiang B.H. Journal of Cellular Physiology 2006, 209:56-66.
28. Arbiser J.L., Kau T., Konar M., Narra K., Ramchandran R., Summers S.A., Vlahos C.J., Ye K., Perry B.N., Matter W., Fischl A., Cook J., Silver P.A., Bain J., Cohen P., Whitmire D., Furness S., Govindarajan B., Bowen J.P. Blood 2007, 109:560-565.
29. Jiang B.H., Liu L.Z. Biochimica et Biophysica Acta 2008, 1784:150-158.
30. Duronio V., Scheid M.P., Ettinger S. Cellular Signalling 1998, 10:233-239.
31. Jiang B.H., Zheng J.Z., Aoki P.K. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:1749-1753.
32. Fingar D.C., Salama S., Tsou C., Harlow E., Blenis J. Genes & Development 2002, 16:1472-1487.
33. Wan X., Harkavy B., Shen N., Grohar P., Helman L.J. Oncogene 2007, 26:1932-1940.